5-[2-fluoro-6-hydroxy-3-[5-(2-methylpropyl)-2,5-dihydro-1H-pyrrol-3-yl]phenyl]-1-oxo-1,2,5-thiadiazolidin-3-one
C16H20FN3O3S — CID 168900444
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[2-fluoro-6-hydroxy-3-[5-(2-methylpropyl)-2,5-dihydro-1H-pyrrol-3-yl]phenyl]-1-oxo-1,2,5-thiadiazolidin-3-one
5-[2-fluoro-6-hydroxy-3-[5-(2-methylpropyl)-2,5-dihydro-1H-pyrrol-3-yl]phenyl]-1-oxo-1,2,5-thiadiazolidin-3-one (PubChem CID 168900444) has the molecular formula C16H20FN3O3S and a molecular weight of 353.42 g/mol. Its IUPAC name is 5-[2-fluoro-6-hydroxy-3-[5-(2-methylpropyl)-2,5-dihydro-1H-pyrrol-3-yl]phenyl]-1-oxo-1,2,5-thiadiazolidin-3-one.
Molecular Properties
| Compound Name | 5-[2-fluoro-6-hydroxy-3-[5-(2-methylpropyl)-2,5-dihydro-1H-pyrrol-3-yl]phenyl]-1-oxo-1,2,5-thiadiazolidin-3-one |
|---|---|
| PubChem CID | 168900444 |
| Molecular Formula | C16H20FN3O3S |
| Molecular Weight | 353.42 g/mol |
| Exact Mass | 353.12 |
| IUPAC Name | 5-[2-fluoro-6-hydroxy-3-[5-(2-methylpropyl)-2,5-dihydro-1H-pyrrol-3-yl]phenyl]-1-oxo-1,2,5-thiadiazolidin-3-one |
| SMILES | CC(C)CC1C=C(c2ccc(O)c(N3CC(=O)NS3=O)c2F)CN1 |
| InChI | InChI=1S/C16H20FN3O3S/c1-9(2)5-11-6-10(7-18-11)12-3-4-13(21)16(15(12)17)20-8-14(22)19-24(20)23/h3-4,6,9,11,18,21H,5,7-8H2,1-2H3,(H,19,22) |
| InChIKey | QVZOUKGFVODJJZ-UHFFFAOYSA-N |
| XLogP | 1.45 |
| TPSA | 81.67 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 353.42 |
| LogP ≤ 5 | 1.45 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168900444 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.